Abstract:OBJECTIVE:To study the effects of BAY-11-7082 on proliferation and apoptosis of U266 cells and its mechanism of action.MATERIALS AND METHODS:Multiple myelomas U266 cells were cultured and divided into control group and gradient-concentration BAY-11-7082 groups (1 μmol/L, 2 μmol/L, 4 μmol/L and 8 μmol/L). Cells in BAY-11-7082 groups were treated with drugs in different concentrations for 4 h, while those in control group were added with an equal volume of solvent. The cell viability was detected via 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay, and lactate dehydrogenase (LDH) release assay was used to detect the cytotoxicity. Furthermore, cells in low-concentration and high-concentration BAY-11-7082 groups were compared with those in control group. The cell proliferation level was evaluated via cell cycle assay, the interleukin-6 (IL-6) level in cells was detected via enzyme-linked immunosorbent assay (ELISA), and the β-catenin protein expression was detected via Western blotting. Moreover, flow cytometry and Hoechst staining were performed to detect the number of apoptotic cells, and the apoptosis level was detected via caspase3 activity and apoptosis-related protein expression. Finally, the levels of p65, p50 and inhibitor kappa B kinase β (IKKβ) were detected via polymerase chain reaction (PCR), and the expressions and changes of phosphorylated (p)-p65 and p-IKKβ were detected via Western blotting.RESULTS:BAY-11-7082 could reduce the U266 cell viability and increase the cytotoxic effect. Based on gradient concentration, 2 μmol/L was selected as the low concentration, while 4 μmol/L was selected as the high concentration. Compared with those in control group, the number of cells in the S and G2/M phases in drug administration groups was significantly decreased, but that in the G0/G1 phase was significantly increased. Besides, the secretion of IL-6 in cells in drug administration groups was significantly decreased compared with that in control group. The β-catenin protein expression was decreased in drug administration groups, and there was also a difference between high concentration group and low concentration group. Flow cytometry and Hoechst staining showed that the proportion of apoptotic cells in drug administration groups was significantly increased. Western blotting and detection of caspase3 activity revealed that the expression and activation of apoptosis-related protein were increased in drug administration groups. It was found in the detection of nuclear factor-κB (NF-κB) pathway that the NF-κB pathway was inhibited in drug administration groups, and there was also a statistically significant difference between high concentration group and low concentration group.CONCLUSIONS:BAY-11-7082 inhibits the proliferation and induces the apoptosis of U266 cells through inhibiting NF-κB pathway.

[The Study of FTY720 on Inducing Apoptosis and Autophagy in Multiple Myeloma Cell Line U266].

Study on Proliferation Inhibiting and Apoptosis Inducing Effects of Cerulenin on Multiple Myeloma Cells

Cerulenin Changes Apoptosis Related Genes Expression in Multiple Myeloma Cell Line U266

[Preliminary Study of Biological Mechanism and Apoptotic Effect Induced by YM155 in SUDHL-4 Cell Line].

Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells.

FTY720 Induces Necrotic Cell Death and Autophagy in Ovarian Cancer Cells: a Protective Role of Autophagy.

Resveratrol Induces AMPK and Mtor Signaling Inhibition-Mediated Autophagy and Apoptosis in Multiple Myeloma Cells.

4-Chlorobenzoyl Berbamine, a Novel Berbamine Derivative, Induces Apoptosis in Multiple Myeloma Cells Through the IL-6 Signal Transduction Pathway and Increases FOXO3a-Bim Expression.

Effect of FTY720 on Lymphocytes Proliferation and Apoptosis of in Vitro Mixed Lymphocytes Reaction

[Berbamine induces apoptosis of multiple myeloma RPMI 8226 cells by activating GADD45/JNK pathway].

The influence of induced autophage in vitro on proliferation of multiple myeloma cells

The influence of induced autophagy in vitro on proliferation of multiple myeloma cells]

FTY720 Induces Apoptosis of M2 Subtype Acute Myeloid Leukemia Cells by Targeting Sphingolipid Metabolism and Increasing Endogenous Ceramide Levels

BAY-11-7082 Induces Apoptosis of Multiple Myeloma U266 Cells Through Inhibiting NF-κB Pathway.

Formosanin C induces autophagy-mediated apoptosis in multiple myeloma cells through the PI3K/AKT/mTOR signaling pathway

Fibroblast Activation Protein Protects Bortezomib-Induced Apoptosis in Multiple Myeloma Cells Through Β-Catenin Signaling Pathway

Molecular Mechanisms of Flavopiridol in Inducing Apoptosis in Multiple Myeloma

[Multiple myeloma cell line U266 apoptosis induced by velcade].

[Research on Multiple Myeloma Cell Apoptosis by Inhibition of Mtorc2 and Chaperon Pathways].

Targeting Autophagy Augments in Vitro and in Vivo Antimyeloma Activity of DNA-damaging Chemotherapy.

Induction of cell cycle arrest and apoptosis by CPUC002 through stabilization of p53 and suppression of STAT3 signaling pathway in multiple myeloma